Hormonal Contraceptives Market Key Players | Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc, and Mylan N.V.

As per the study initiated by Evolve Business Intelligence, the global Hormonal Contraceptives Market size accounted for USD 18.22 Billion in 2023, growing at a CAGR of 3.31% from 2023 to 2033. Hormonal contraceptives refer to a category of birth control methods that use synthetic hormones to regulate a woman's reproductive system and prevent pregnancy. These contraceptives typically contain either a combination of estrogen and progestin (combined hormonal contraceptives) or progestin alone (progestin-only contraceptives). Common forms of hormonal contraceptives include birth control pills, patches, injectables, and hormonal intrauterine devices (IUDs). They work by suppressing ovulation, thickening cervical mucus to impede sperm movement, and thinning the uterine lining to discourage implantation. Hormonal contraceptives are widely used for their effectiveness and convenience in providing reversible and reliable birth control options for women.

Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021893

The Hormonal Contraceptives market is primarily driven by the increasing awareness of family planning, coupled with the demand for effective and convenient birth control methods. Ongoing advancements in hormonal contraceptive formulations, offering improved safety profiles and varied delivery mechanisms, further contribute to the market's growth.

Key Players
Some of the major Hormonal Contraceptives Market players holding high market shares include Female Health Company, Teva Pharmaceutical Industries Limited, Bayer AG, Pfizer, Inc, and Mylan N.V. These players use partnership and collaboration as key strategies to gain significant market share to compete with market leaders. Some of the other major market players include Johnson & Johnson, Ansell LTD., Mayer Laboratories, Merck & Co., Inc.

Report Description: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021893

Segmental Analysis
Based on Product, the Hormonal Contraceptives market is segmented into Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, and Transdermal Patches. The dominance of the Oral Contraceptive Pills segment in the Hormonal Contraceptives market is propelled by their widespread popularity and user-friendly administration, providing a convenient and highly effective daily birth control option for women.
Based on the Hormones, the Hormonal Contraceptives market is segmented into Progestin-only Contraceptives and Combined Hormonal Contraceptives. The dominance of the Progestin-only Contraceptive segment in the Hormonal Contraceptives market is propelled by its suitability for women with contraindications to estrogen, offering a reliable and hormone-based birth control option with reduced side effects and broader accessibility.

Based on End Users, the Hormonal Contraceptives market is segmented into Hospitals, Household, and Clinics. The dominance of the Hospitals segment in the Hormonal Contraceptives market is propelled by the widespread provision of comprehensive family planning services and the administration of hormonal contraceptives within hospital settings, ensuring accessibility and professional guidance for women seeking birth control options.

Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.